Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Targeting the epidermal growth factor receptor in non-small cell lung cancer cells: the effect of combining RNA interference with tyrosine kinase inhibitors or cetuximab

  • Gang Chen1, 2,
  • Peter Kronenberger1, 3,
  • Erik Teugels1,
  • Ijeoma Adaku Umelo1 and
  • Jacques De Grève1Email author
BMC Medicine201210:28

DOI: 10.1186/1741-7015-10-28

Received: 27 November 2011

Accepted: 21 March 2012

Published: 21 March 2012

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
27 Nov 2011 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
30 Nov 2011 Author responded Author comments - Gang Chen
Resubmission - Version 3
30 Nov 2011 Submitted Manuscript version 3
5 Jan 2012 Reviewed Reviewer Report - Apar Kishor Ganti
17 Jan 2012 Reviewed Reviewer Report - Lucio Crinò
25 Jan 2012 Author responded Author comments - Gang Chen
Resubmission - Version 4
25 Jan 2012 Submitted Manuscript version 4
14 Feb 2012 Author responded Author comments - Gang Chen
Resubmission - Version 5
14 Feb 2012 Submitted Manuscript version 5
Publishing
21 Mar 2012 Editorially accepted
21 Mar 2012 Article published 10.1186/1741-7015-10-28

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article.. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Laboratory of Medical and Molecular Oncology and Department of Medical Oncology, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel
(2)
Department of Pathology, First Affiliated Hospital, Guangxi Medical University
(3)
Laboratory for Biotechnology, Department of Gezondheidszorg, Erasmushogeschool Brussel

Advertisement